JAK2 and myeloproliferative disorder: The creation of a model of JAK2-CH is not straightforward because multiple mouse lines that harbor the Jak2V617F mutation in their hematopoietic stem and progenitor cells (HSPC) exhibit MPN phenotypes that confound the CVD phenotype under investigation.